SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001104659-24-059673
Filing Date
2024-05-10
Accepted
2024-05-10 09:07:23
Documents
10
Effectiveness Date
2024-05-10

Document Format Files

Seq Description Document Type Size
1 S-3ASR tm2413802d1_s3asr.htm S-3ASR 453530
2 EXHIBIT 1.2 tm2413802d1_ex1-2.htm EX-1.2 247164
3 EXHIBIT 4.4 tm2413802d1_ex4-4.htm EX-4.4 324518
4 EXHIBIT 5.1 tm2413802d1_ex5-1.htm EX-5.1 29549
5 EXHIBIT 23.1 tm2413802d1_ex23-1.htm EX-23.1 2036
6 EX-FILING FEES tm2413802d1_ex-filingfees.htm EX-FILING FEES 24548
7 GRAPHIC tm2413802d1_ex5-1img001.jpg GRAPHIC 4277
8 GRAPHIC tm2413802d1_s3asrimg001.jpg GRAPHIC 27172
9 GRAPHIC tm2413802d1_s3asrimg002.jpg GRAPHIC 24653
10 GRAPHIC tm2413802d1_s3asrimg003.jpg GRAPHIC 22675
  Complete submission text file 0001104659-24-059673.txt   1191528
Mailing Address 1715 38TH ST BOULDER CO 80301
Business Address 1715 38TH ST BOULDER CO 80301 720-262-7002
Edgewise Therapeutics, Inc. (Filer) CIK: 0001710072 (see all company filings)

IRS No.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-279299 | Film No.: 24933059
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)